Dose-modified gemcitabine plus nab-paclitaxel front-line in advanced pancreatic ductal adenocarcinoma with baseline hyperbilirubinemia
Rogers, Jane E., Mizrahi, Jonathan D., Shroff, Rachna T., Nelson, Douglas A., Tu, Janet, Javle, Milind M., Wolff, Robert A., Pant, ShubhamVolume:
11
Language:
english
Journal:
Journal of Gastrointestinal Oncology
DOI:
10.21037/jgo.2019.10.05
Date:
February, 2020
File:
PDF, 183 KB
english, 2020